FDA Stays Parts of Guidance on Clinical Research Involving Foods
date:Nov 06, 2015
In response to stakeholder comments, including those from IDFA, the Food and Drug Administration is staying select parts of its final guidance on Investigational New Drug (IND) applications. The guidance was issued in 2013 to guide clinical research studies, including those involving food.

IDFA and several other trade associations submitted comments in 2014 that pushed back against the guidance, saying it was overly burdensome and fundamentally flawed. IDFAs comments outlined how the guidance c

05/17 10:33